// App-Quantinova.ai

MEDU-29 : A novel mouse model of PI3 kinase pathway in metastatic Shh medulloblastoma

Researchers

Presenter

  • Michael Taylor

Principal Investigators

  • N/A

Medical Centers

  • Hospital for Sick Children, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Peptidase inhibitor 3

Drug/Treatment

  • Doxycycline

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A